The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.45
Bid: 18.30
Ask: 18.60
Change: 0.25 (1.37%)
Spread: 0.30 (1.639%)
Open: 18.20
High: 0.00
Low: 0.00
Prev. Close: 18.20
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter 2019 update

5 Nov 2019 12:07

RNS Number : 3397S
LMS Capital PLC
05 November 2019
 

5 November 2019

 

 

LMS Capital plc

3rd Quarter 2019 update

 

 

LMS Capital plc ("LMS" or "the Company") is issuing the following update covering the period from 1 July 2019 to date.

 

30 September 2019 Net Asset Value

 

The Company's unaudited net asset value ("NAV") at 30 September 2019 was £58.7 million (30 June 2019 £59.1 million), equivalent to 72.7p per share (30 June 2019: 73.3p per share). The most significant movements in net asset value during the quarter were:

 

·; Realised and unrealised movements in the valuation of investments compared to valuations at 30 June 2019 led to a £0.3 million reduction in NAV, excluding the impact of exchange rate movements. The principal items were:

o As announced by the Company on 14 August 2019, an increase of £2.4 million in the net proceeds on the sale of Entuity, with a corresponding increase in NAV, over and above the net proceeds recognised in the 30 June 2019 valuation. This reflected the sale not only of all the Company's shares, but also the repayment of all working capital loans;

o Increases of £0.6 million and £0.4m in the value of quoted shares in IDE Group and Solaredge respectively;

o a reduction in value of Medhost of £2.0 million reflecting a corresponding reduction by Primus, the lead investor, in its latest available fund report;

o a reduction of £2.4 million in value of YesTo following discussions with the third party fund manager. The reduction reflects a deterioration in trading in 2019 and requirement to make consequential changes in the management and operating structure of the company, which changes are already in process of being made;

·; Weakening of sterling against the US Dollar in the period to 30 September 2019 has resulted in an unrealised exchange gain of £0.5 million; and

·; Other net changes amount to a £0.7 million reduction, the main item of which is overhead costs.

 

Net cash balances at 30 September 2019 were £28.5 million (30 June 2019: £16.4 million), the increase being principally due to the receipt of the sale proceeds on Entuity which were announced by the Company on 14 August 2019. The final proceeds from amounts held in escrow in relation to the sale of Penguin, totaling £0.9 million, were also received.

 

The NAV at the end of September is based on the valuation of the Company's investments as at 30 June 2019, adjusted for transactions in the three months ended 30 September 2019, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, latest information from third party fund managers, purchases and sales of quoted and unquoted securities and operating expenses.

 

Since the end of September, further movements in the prices of the Company's quoted investments and changes in the sterling/US Dollar exchange rate have not had a material impact (either individually or in aggregate) on the Company's NAV as at the end of September.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse regulations (EU) No. 596/2014. Upon publication of this announcement this inside information is now considered to be in the public domain.

 

For further information please contact

 

LMS Capital plc

Martin Knight, Chairman 0203 837 6270

 

Gresham House Asset Management Limited

Graham Bird 0203 837 6270

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley 0207 742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVUGGWUGUPBGPA
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.